INFeD is a Intramuscular; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Iron Dextran.
| Product ID | 52544-931_1c08ecbf-f199-47bd-8a78-4c2d43d215c5 |
| NDC | 52544-931 |
| Product Type | Human Prescription Drug |
| Proprietary Name | INFeD |
| Generic Name | Iron Dextran |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 1974-04-29 |
| Marketing End Date | 2021-08-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA017441 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | IRON DEXTRAN |
| Active Ingredient Strength | 50 mg/mL |
| Pharm Classes | Iron [CS],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Marketing Start Date | 1974-04-29 |
| Marketing End Date | 2021-08-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA017441 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1974-04-29 |
| Marketing End Date | 2021-08-31 |
| Ingredient | Strength |
|---|---|
| IRON DEXTRAN | 50 mg/mL |
| SPL SET ID: | abacb7fa-2fc2-471e-9200-944eeac8ca2a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0023-6082 | INFeD | Iron Dextran |
| 0404-9879 | INFED | iron dextran |
| 52544-931 | INFeD | Iron Dextran |
| 52584-086 | INFED | iron dextran |
| 52584-931 | Infed | Iron Dextran |
| 51662-1441 | IRON DEXTRAN | IRON DEXTRAN |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() INFED 74185675 1717425 Live/Registered |
ALLERGAN SALES, LLC 1991-07-16 |